DK3153163T3 - Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf - Google Patents
Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf Download PDFInfo
- Publication number
- DK3153163T3 DK3153163T3 DK15821314.0T DK15821314T DK3153163T3 DK 3153163 T3 DK3153163 T3 DK 3153163T3 DK 15821314 T DK15821314 T DK 15821314T DK 3153163 T3 DK3153163 T3 DK 3153163T3
- Authority
- DK
- Denmark
- Prior art keywords
- glycerides
- formulation
- compound containing
- pharmaceutical compound
- pharmaceutical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410342799.2A CN105267197B (zh) | 2014-07-18 | 含有13种甘油酯的药物组合物、制剂及其应用 | |
PCT/CN2015/084295 WO2016008441A1 (zh) | 2014-07-18 | 2015-07-17 | 含有13种甘油酯的药物组合物、制剂及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3153163T3 true DK3153163T3 (da) | 2019-08-12 |
Family
ID=55073638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15821314.0T DK3153163T3 (da) | 2014-07-18 | 2015-07-17 | Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US9585858B2 (da) |
EP (1) | EP3153163B1 (da) |
JP (1) | JP6473801B2 (da) |
KR (1) | KR20170031146A (da) |
AP (1) | AP2017009706A0 (da) |
AU (1) | AU2015291530B2 (da) |
CA (1) | CA2954792C (da) |
DK (1) | DK3153163T3 (da) |
EA (1) | EA033077B1 (da) |
NZ (1) | NZ726582A (da) |
PL (1) | PL3153163T3 (da) |
SG (1) | SG11201700122TA (da) |
WO (1) | WO2016008441A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6113133B2 (ja) * | 2014-11-06 | 2017-04-12 | 日本メナード化粧品株式会社 | 幹細胞の未分化状態維持剤及び増殖促進剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1029293C (zh) * | 1993-01-01 | 1995-07-12 | 浙江省中医院 | 薏苡仁中性油脂乳剂 |
PH30249A (en) * | 1992-09-16 | 1997-02-05 | Zhejiang Provincial Hospital O | Neutral lipids from endosperm of job's tears |
CN1029662C (zh) * | 1992-09-17 | 1995-09-06 | 李大鹏 | 薏苡仁中性油脂及其提取方法 |
JP2002212586A (ja) * | 2001-01-19 | 2002-07-31 | Kanegafuchi Chem Ind Co Ltd | 油脂の精製方法 |
CN1200995C (zh) * | 2002-09-28 | 2005-05-11 | 李大鹏 | 超临界二氧化碳提取薏苡仁粗油方法 |
CN1234828C (zh) * | 2002-11-21 | 2006-01-04 | 上海高科联合生物技术研发有限公司 | 超临界二氧化碳萃取薏苡仁油的方法 |
CN1778380A (zh) * | 2004-11-23 | 2006-05-31 | 乔志亚生技股份有限公司 | 薏仁油萃取的方法及组成分及其疗效 |
CN101036761B (zh) * | 2007-04-23 | 2010-05-19 | 肖志勇 | 一种薏苡仁油的制备方法 |
CN101940738A (zh) * | 2010-07-27 | 2011-01-12 | 辽宁中医药大学 | 薏苡仁抗癌中药及其制备方法 |
CN102177978B (zh) * | 2011-04-14 | 2013-01-30 | 西南大学 | 薏苡仁米糠及其运用 |
US20140370129A1 (en) * | 2013-06-14 | 2014-12-18 | Zhejiang Kanglaite Group Co., Ltd. | Dosing regimen and method for treating cancer using a coix seed oil emulsion |
CN104173824B (zh) * | 2014-07-18 | 2017-02-15 | 浙江康莱特集团有限公司 | 含有8种甘油三酯的薏苡仁油、制剂及其应用 |
-
2015
- 2015-06-08 US US14/733,098 patent/US9585858B2/en active Active
- 2015-07-17 SG SG11201700122TA patent/SG11201700122TA/en unknown
- 2015-07-17 CA CA2954792A patent/CA2954792C/en active Active
- 2015-07-17 AU AU2015291530A patent/AU2015291530B2/en active Active
- 2015-07-17 PL PL15821314T patent/PL3153163T3/pl unknown
- 2015-07-17 KR KR1020177001303A patent/KR20170031146A/ko active Search and Examination
- 2015-07-17 NZ NZ726582A patent/NZ726582A/en unknown
- 2015-07-17 AP AP2017009706A patent/AP2017009706A0/en unknown
- 2015-07-17 JP JP2017503156A patent/JP6473801B2/ja active Active
- 2015-07-17 EA EA201790117A patent/EA033077B1/ru not_active IP Right Cessation
- 2015-07-17 EP EP15821314.0A patent/EP3153163B1/en active Active
- 2015-07-17 DK DK15821314.0T patent/DK3153163T3/da active
- 2015-07-17 WO PCT/CN2015/084295 patent/WO2016008441A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2015291530A1 (en) | 2016-12-08 |
PL3153163T3 (pl) | 2019-11-29 |
EA201790117A1 (ru) | 2017-07-31 |
EP3153163B1 (en) | 2019-05-22 |
SG11201700122TA (en) | 2017-03-30 |
NZ726582A (en) | 2018-06-29 |
KR20170031146A (ko) | 2017-03-20 |
EP3153163A4 (en) | 2017-05-17 |
JP6473801B2 (ja) | 2019-02-20 |
CA2954792A1 (en) | 2016-01-21 |
CA2954792C (en) | 2019-10-29 |
CN105267197A (zh) | 2016-01-27 |
AU2015291530B2 (en) | 2018-03-15 |
EP3153163A1 (en) | 2017-04-12 |
US20160015672A1 (en) | 2016-01-21 |
AP2017009706A0 (en) | 2017-01-31 |
WO2016008441A1 (zh) | 2016-01-21 |
US9585858B2 (en) | 2017-03-07 |
EA033077B1 (ru) | 2019-08-30 |
JP2017524697A (ja) | 2017-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248688A1 (zh) | 多環氨甲醯基吡啶酮化合物及其藥物用途 | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
DK3529248T3 (da) | Farmaceutiske sammensætninger | |
BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
MA50541A (fr) | Formulations pharmaceutiques | |
DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
MA42303A (fr) | Formulations pharmaceutiques | |
MA46867A (fr) | Formulations pharmaceutiques | |
DK3634377T3 (da) | Farmaceutisk formulering | |
DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
DK3821905T3 (da) | Insulin indeholdende farmaceutiske sammensætninger | |
IL248785B (en) | Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents | |
BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
DK3383397T3 (da) | Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin | |
DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
DK3229843T3 (da) | Farmaceutisk sammensætning, præparat og anvendelser deraf | |
DK3129057T3 (da) | Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi | |
DK3280447T3 (da) | Farmaceutiske formuleringer | |
DK3601277T3 (da) | Farmaceutisk formulering | |
DK4023651T3 (da) | Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme | |
DK3463365T3 (da) | Farmaceutisk antifungal formulering |